The increase of biomarkers like S100B and S-SNE has been reported with serum Mg levels below 1.2 mmol/L, and is associated with poor outcomes and a higher rate of mortality in patients with stroke (James et al., 2009[69]; Mirrahimi et al., 2015[107]). This evidence concerns the gene S100B and stroke disorder.